Centessa Pharmaceuticals's total assets for Q1 2025 were $527.85M, a decrease of -8.49% from the previous quarter. CNTA total liabilities were $141.60M for the fiscal quarter, a -19.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.